SCHEMBL5095773

SCHEMBL5095773

NC(=O)N(CCCCN1CCCN(c2cccc3c2OCCCC3)CC1)c1cc2cc(Br)ccc2o1.NC(=O)Nc1oc2ccccc2c1CCCCN1CCCN(c2cccc3c2OCCCC3)CC1

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 14/20 0.38
DRD3 P35462 8/20 0.38
DRD4 P21917 6/20 0.38
HTR1A P08908 8/20 0.35
HTR2A P28223 7/20 0.35
HTR2C P28335 4/20 0.33
DRD1 P21728 1/20 0.32
HTR2B P41595 1/20 0.32
BACE1 P56817 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138386 0.98 DRD2 (0.39) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4950739 0.89 DRD2 (0.44) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4949917 0.87 DRD2 (0.44) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4952106 0.87 DRD2 (0.45) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4949751 0.87 DRD2 (0.42) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4946000 0.86 DRD2 (0.45) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL5088776 0.85 DRD2 (0.35) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4947399 0.85 DRD2 (0.46) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4953433 0.85 DRD2 (0.42) DRD2DRD3DRD4HTR1AHTR2A
SCHEMBL4952079 0.85 DRD2 (0.43) DRD2DRD3HTR1AHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2008526700-A 2008-07-24 JP claimed
EP-1761524-A1 PHENYL DIAZEPANE CARBOXAMIDES AND ANNELATED PHENYL PIPERAZINE CARBOXAMIDES CONTAINING OXYGEN AND USED AS DOPAMINE D3 ANTAGONISTS SCHWARZ PHARMA AG (DE) 2007-03-14 EP claimed
WO-2006072430-A1 PHENYL DIAZEPANE CARBOXAMIDES AND ANNELATED PHENYL PIPERAZINE CARBOXAMIDES CONTAINING OXYGEN AND USED AS DOPAMINE D3 ANTAGONISTS SCHWARZ PHARMA AG (DE) 2006-07-13 WO claimed